<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:a2765229-3df6-415d-b7c5-0866c6afcb29,g:49b9860e-fa68-4fa1-9959-e27eca5ad553,d:e757d966bc7e4edaa28b393d5bf14348--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>anab-20230207</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF80L2ZyYWc6ZjBhZjcwMWQ2MGYxNGQ0OWE3NTM2NjA1ZjY1NTZkZWUvdGFibGU6OGJhMGFjZTFiMTg5NGU2MDgyOWIxY2I4NGJiNWMyYmMvdGFibGVyYW5nZTo4YmEwYWNlMWIxODk0ZTYwODI5YjFjYjg0YmI1YzJiY18yLTEtMS0xLTYzNTI3_4387ba49-958e-4939-a9fa-9b90c3f8a378">0001370053</ix:nonNumeric><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF80L2ZyYWc6ZjBhZjcwMWQ2MGYxNGQ0OWE3NTM2NjA1ZjY1NTZkZWUvdGFibGU6OGJhMGFjZTFiMTg5NGU2MDgyOWIxY2I4NGJiNWMyYmMvdGFibGVyYW5nZTo4YmEwYWNlMWIxODk0ZTYwODI5YjFjYjg0YmI1YzJiY18zLTEtMS0xLTYzNzE2_0222e640-31bd-4ad8-b373-d61d450b68de">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF80L2ZyYWc6ZjBhZjcwMWQ2MGYxNGQ0OWE3NTM2NjA1ZjY1NTZkZWUvdGFibGU6OGJhMGFjZTFiMTg5NGU2MDgyOWIxY2I4NGJiNWMyYmMvdGFibGVyYW5nZTo4YmEwYWNlMWIxODk0ZTYwODI5YjFjYjg0YmI1YzJiY181LTEtMS0xLTYzNTI3_f548de14-03bf-4ad0-9084-918ffba64756">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="anab-20230207.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001370053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-07</xbrli:startDate><xbrli:endDate>2023-02-07</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie757d966bc7e4edaa28b393d5bf14348_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzYy_4f0a6564-d51c-44a6-bf61-7a8ff907a6a8">8-K</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT PURSUANT TO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date of Report: <ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xOTE_22bf7c3d-948f-4687-a29a-a101534f497f">February 7, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Date of earliest event reported)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzcz_2159ff39-5723-4ed7-bd0c-0fa5bcdee507">ANAPTYSBIO, INC</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.857%"><tr><td style="width:1.0%"></td><td style="width:33.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGFibGU6YzNkYWQ3M2E5MzliNDFiMDk0ODBiZTExNTYwZmI3ZmYvdGFibGVyYW5nZTpjM2RhZDczYTkzOWI0MWIwOTQ4MGJlMTE1NjBmYjdmZl8wLTAtMS0xLTYzNTI3_6e81c250-20d3-43f0-b1bc-82384b5865ed">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGFibGU6YzNkYWQ3M2E5MzliNDFiMDk0ODBiZTExNTYwZmI3ZmYvdGFibGVyYW5nZTpjM2RhZDczYTkzOWI0MWIwOTQ4MGJlMTE1NjBmYjdmZl8wLTEtMS0xLTYzNTI3_ba97f833-e279-4c46-81a3-eb2562003d20">001-37985</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGFibGU6YzNkYWQ3M2E5MzliNDFiMDk0ODBiZTExNTYwZmI3ZmYvdGFibGVyYW5nZTpjM2RhZDczYTkzOWI0MWIwOTQ4MGJlMTE1NjBmYjdmZl8wLTItMS0xLTYzNTI3_5277cde9-79e5-435f-87a5-baa22936c054">20-3828755</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzY5_df156b21-882d-46b1-8384-09728a7e26b6">10770 Wateridge Circle</ix:nonNumeric>, <ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzYz_fcc31df3-061d-43fb-a76c-4c6380e202fa">Suite 210,</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzU3_47a06ffd-7bc4-4177-bbc8-8ef0ee977a2f">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzY1_c7a3c7ec-58c1-4c3e-87a8-e63b8f8ee914">CA</ix:nonNumeric>  <ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzU4_33ce1141-6643-4f72-9737-7a16655cb9b6">92121</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices, and Zip Code)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzcw_5d9f454d-f62f-425e-8cb7-9d4cd6da89ff">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzcx_4f1617c4-17db-4139-a922-cd14956a1418">362-6295</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzYw_be8a3ee4-8120-42dd-9756-171dcbcb1e45">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communication pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzY2_19e64771-1772-49e0-843d-65fd490e9fe7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzcy_d48c218c-fca5-437c-8053-afed0cd2c1ef">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communication pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzY3_3f41c99b-5397-473c-a1c2-fd836360e7f9">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communication pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.866%"><tr><td style="width:1.0%"></td><td style="width:35.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGFibGU6ZjRiODM4ZmZjNjAyNDZlZTgxZmQ3NmVlNDhmNDVhODUvdGFibGVyYW5nZTpmNGI4MzhmZmM2MDI0NmVlODFmZDc2ZWU0OGY0NWE4NV8xLTAtMS0xLTYzNTI3_e60699b3-a818-491e-b364-d0896663ccd8">Common Stock, par value $0.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGFibGU6ZjRiODM4ZmZjNjAyNDZlZTgxZmQ3NmVlNDhmNDVhODUvdGFibGVyYW5nZTpmNGI4MzhmZmM2MDI0NmVlODFmZDc2ZWU0OGY0NWE4NV8xLTEtMS0xLTYzNTI3_7bece51a-71a2-4b95-9e7f-65a238c7eb10">ANAB</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGFibGU6ZjRiODM4ZmZjNjAyNDZlZTgxZmQ3NmVlNDhmNDVhODUvdGFibGVyYW5nZTpmNGI4MzhmZmM2MDI0NmVlODFmZDc2ZWU0OGY0NWE4NV8xLTItMS0xLTYzNTI3_6021ccad-5665-40a5-88c9-a01d80059b42">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9eaf6a405f714ce295af350fd34e4c32_D20230207-20230207" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU3NTdkOTY2YmM3ZTRlZGFhMjhiMzkzZDViZjE0MzQ4L3NlYzplNzU3ZDk2NmJjN2U0ZWRhYTI4YjM5M2Q1YmYxNDM0OF8xL2ZyYWc6OWRiNDUzYjFlMjUzNDE4YTlmNDNhZWFjYzYxNTZkMGEvdGV4dHJlZ2lvbjo5ZGI0NTNiMWUyNTM0MThhOWY0M2FlYWNjNjE1NmQwYV8xNzY4_8fb9a7d9-48d6-4952-8a85-397aafac2c5f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie757d966bc7e4edaa28b393d5bf14348_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:5pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item&#160;5.03.&#160;&#160;&#160;&#160;Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On February 7, 2023, in connection with the effectiveness of new Securities and Exchange Commission rules regarding universal proxy cards, certain recent changes to the Delaware General Corporation Law (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">DGCL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and a periodic review of the bylaws of AnaptysBio, Inc. (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Company&#8217;s board of directors (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Board</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) approved and adopted the Company&#8217;s second amended and restated bylaws (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Second Amended and Restated Bylaws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), which became immediately effective.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Among other things, the amendments effected by the Second Amended and Restated Bylaws:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">revise certain provisions relating to adjournment procedures and lists of stockholders entitled to vote at stockholder meetings, in each case to conform to recent amendments to the DGCL;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">update certain provisions related to the conduct of stockholder meetings, including clarifying that the presiding person of a stockholder meeting may set additional attendance or other procedures for meeting attendees and Rule 14a-8 proponents;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">revise the procedures and disclosure requirements set forth in the advance notice bylaw provisions, including (1) requiring additional information, representations and disclosures from proposing stockholders, proposed nominees and other persons related to a stockholder&#8217;s solicitation of proxies, (2) restricting the number of nominees a stockholder may nominate for election at a meeting to the number of directors to be elected at such meeting, (3) requiring that proposed nominees be available for interviews by the Board or any Board committee thereof;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">address matters relating to Rule 14a-19 under the Securities Exchange Act of 1934, as amended (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Universal Proxy Rules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> providing that stockholders delivering a notice of nomination certify to the Company in writing that they have complied with the Universal Proxy Rules requirements, providing the Company a remedy if a stockholder fails to satisfy the Universal Proxy Rules requirements, requiring that a stockholder providing notice pursuant to the advance notice bylaws to inform the Company if a stockholder no longer plans to solicit proxies in accordance with the Universal Proxy Rules, and requiring stockholders intending to use the Universal Proxy Rules to provide reasonable evidence of the satisfaction of the requirements under the Universal Proxy Rules at least five business days before the meeting, etc.);</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">require that a stockholder directly or indirectly soliciting proxies from other stockholders use a proxy card color other than white;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">require that a stockholder intending to authorize a qualified representative to act for such stockholder as a proxy to present a nomination or proposal at such meeting to give notice of such authorization to the Company at least three business days before the applicable meeting;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">amend the notice provisions to reflect amendments to the DGCL relating to electronic transmission of notices to stockholders;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">add an emergency bylaw provision to provide clarity and authority to directors and certain officers during an emergency situation that would otherwise prevent a quorum of the Board or a Board committee from being achieved; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">provides that, unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States, shall be the sole and exclusive forum for any complaint asserting a cause of action arising under the Securities Act of 1933, as amended.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Second Amended and Restated Bylaws also incorporate ministerial, clarifying and conforming changes, including changes to align with the language used in certain provisions of the DGCL and the Universal Proxy Rules. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the full text of the Second Amended and Restated Bylaws, a copy of which is attached hereto as Exhibit 3.1 and is incorporated herein by reference.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 9.01.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Financial Statements and Exhibits. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Exhibit Title or Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline" href="anaptysbio-secondamended.htm">3.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Second Amended and Restated Bylaws of AnaptysBio, Inc. (as amended and restated on February 7, 2023).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">SIGNATURES</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AnaptysBio, Inc.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date:  February 10, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">/s/Dennis Mulroy</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Name: Dennis Mulroy</span></div></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Title: Chief Financial Officer</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "anab-20230207.htm", "description": "8-K", "secsgml_size_bytes": 41215}]
{"company-data": {"conformed-name": "ANAPTYSBIO, INC", "cik": "0001370053", "assigned-sic": "2834", "irs-number": "203828755", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-37985", "film-number": "23611898"}, "business-address": {"street1": "10770 WATERIDGE CIRCLE, SUITE 210", "city": "SAN DIEGO", "state": "CA", "zip": "92121", "phone": "858-362-6295"}, "mail-address": {"street1": "10770 WATERIDGE CIRCLE, SUITE 210", "city": "SAN DIEGO", "state": "CA", "zip": "92121"}, "former-company": [{"former-conformed-name": "ANAPTYSBIO INC", "date-changed": "20080828"}, {"former-conformed-name": "ANAPTYS BIOSCIENCES INC", "date-changed": "20060724"}]}
anab-20230207
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report:
February 7, 2023
(Date of earliest event reported)
ANAPTYSBIO, INC
.
(Exact Name of Registrant as Specified in Charter)
Delaware
001-37985
20-3828755
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
10770 Wateridge Circle
,
Suite 210,
San Diego
,
CA
92121
(Address of Principal Executive Offices, and Zip Code)
(
858
)
362-6295
(Registrant's Telephone Number, Including Area Code)
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
ANAB
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
(17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.03.    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
On February 7, 2023, in connection with the effectiveness of new Securities and Exchange Commission rules regarding universal proxy cards, certain recent changes to the Delaware General Corporation Law (the "
DGCL
"), and a periodic review of the bylaws of AnaptysBio, Inc. (the "
Company
"), the Company's board of directors (the "
Board
") approved and adopted the Company's second amended and restated bylaws (the "
Second Amended and Restated Bylaws
"), which became immediately effective.
Among other things, the amendments effected by the Second Amended and Restated Bylaws:
•
revise certain provisions relating to adjournment procedures and lists of stockholders entitled to vote at stockholder meetings, in each case to conform to recent amendments to the DGCL;
•
update certain provisions related to the conduct of stockholder meetings, including clarifying that the presiding person of a stockholder meeting may set additional attendance or other procedures for meeting attendees and Rule 14a-8 proponents;
•
revise the procedures and disclosure requirements set forth in the advance notice bylaw provisions, including (1) requiring additional information, representations and disclosures from proposing stockholders, proposed nominees and other persons related to a stockholder's solicitation of proxies, (2) restricting the number of nominees a stockholder may nominate for election at a meeting to the number of directors to be elected at such meeting, (3) requiring that proposed nominees be available for interviews by the Board or any Board committee thereof;
•
address matters relating to Rule 14a-19 under the Securities Exchange Act of 1934, as amended (the "
Universal Proxy Rules
") (
e.g.,
providing that stockholders delivering a notice of nomination certify to the Company in writing that they have complied with the Universal Proxy Rules requirements, providing the Company a remedy if a stockholder fails to satisfy the Universal Proxy Rules requirements, requiring that a stockholder providing notice pursuant to the advance notice bylaws to inform the Company if a stockholder no longer plans to solicit proxies in accordance with the Universal Proxy Rules, and requiring stockholders intending to use the Universal Proxy Rules to provide reasonable evidence of the satisfaction of the requirements under the Universal Proxy Rules at least five business days before the meeting, etc.);
•
require that a stockholder directly or indirectly soliciting proxies from other stockholders use a proxy card color other than white;
•
require that a stockholder intending to authorize a qualified representative to act for such stockholder as a proxy to present a nomination or proposal at such meeting to give notice of such authorization to the Company at least three business days before the applicable meeting;
•
amend the notice provisions to reflect amendments to the DGCL relating to electronic transmission of notices to stockholders;
•
add an emergency bylaw provision to provide clarity and authority to directors and certain officers during an emergency situation that would otherwise prevent a quorum of the Board or a Board committee from being achieved; and
•
provides that, unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States, shall be the sole and exclusive forum for any complaint asserting a cause of action arising under the Securities Act of 1933, as amended.
The Second Amended and Restated Bylaws also incorporate ministerial, clarifying and conforming changes, including changes to align with the language used in certain provisions of the DGCL and the Universal Proxy Rules.
The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the full text of the Second Amended and Restated Bylaws, a copy of which is attached hereto as Exhibit 3.1 and is incorporated herein by reference.
Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number
Exhibit Title or Description
3.1
Second Amended and Restated Bylaws of AnaptysBio, Inc. (as amended and restated on February 7, 2023).
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
AnaptysBio, Inc.
Date:  February 10, 2023
By:
/s/Dennis Mulroy
Name: Dennis Mulroy
Title: Chief Financial Officer